Immunopathogenesis of human schistosomiasis

Parasite Immunology

Volumn 31, Issue 4, 2009, Pages 163-176

  Burke, M L ^b,c   Jones, M K ^b,c   Gobert, G N ^b   Li, Y S ^b   Ellis, M K ^b   McManus, D P ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Chemokine; Cytokine; Fibrosis; Immunopathogenesis; Immunopathology

Indexed keywords

ARTEMETHER; CARBON TETRACHLORIDE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; EOTAXIN; EOTAXIN 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; PRAZIQUANTEL; RANTES; SCHISTOSOMA VACCINE; STEROID; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ANOREXIA; ANTIBODY DETECTION; BLOODY DIARRHEA; CD4+ T LYMPHOCYTE; CELL TYPE; COUGHING; CROHN DISEASE; DERMATITIS; DISEASE COURSE; DISEASE MODEL; EOSINOPHILIA; FATIGUE; FEVER; GENE CONTROL; GRANULOMATOUS INFLAMMATION; HEADACHE; HOST; HUMAN; HYDRONEPHROSIS; HYDROURETER; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; KIDNEY COLIC; KIDNEY FAILURE; LIVER; LIVER FIBROSIS; LUNG INFILTRATE; MACROPHAGE; MACULOPAPULAR RASH; MALAISE; MOLECULAR MECHANICS; MYALGIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PRURITUS; REGULATORY T LYMPHOCYTE; REVIEW; SARCOIDOSIS; SCHISTOSOMA; SCHISTOSOMIASIS; STELLATE CELL; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; THORAX RADIOGRAPHY; ULTRASOUND;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FIBROSIS; GRANULOMA; HUMANS; LIVER; POLYMORPHISM, GENETIC; SCHISTOSOMIASIS; T-LYMPHOCYTES, HELPER-INDUCER; UROGENITAL SYSTEM;

ANIMALIA; MURINAE; SCHISTOSOMA;

EID: 62149121988     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01098.x     Document Type: Review

References (149)

1. Gryseels B, Polman K, Clerinx J Kestens L. Human schistosomiasis. Lancet 2006 368 : 1106 1118.
2. Pearce EJ MacDonald AS. The Immunobiology of Schistosomiasis. Nat Rev Immunol 2002 2 : 499 511.
3. Ross AG, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med 2002 346 : 1212 1220.
4. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol 2007 85 : 148 154.
5. Wynn TA, Thompson RW, Cheever AW Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004 201 : 156 167.
6. Abath FG, Morais CN, Montenegro CE, Wynn TA Montenegro SM. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol 2006 22 : 85 91.
7. Caldas IR, Campi-Azevedo AC, Oliveira LF, Silveira AM, Oliveira RC Gazzinelli G. Human schistosomiasis mansoni: Immune responses during acute and chronic phases of the infection. Acta Trop 2008.
8. Ross AG, Vickers D, Olds GR, Shah SM McManus DP. Katayama Syndrome. Lancet Infect Dis 2007 : 7.
9. King CL. Initiation and regulation of disease in schistosomiasis. In : Mahmoud AA (ed.) : Schistosomiasis. London, Imperial College Press, 2001 : 213 264.
10. Olveda RM. Disease in schistosomiasis japonica. In : Mahmoud AA (ed.) : Schistosomiasis. London, Imperial College Press, 2001 : 361 389.
11. Ross AG, Sleigh AC, Li Y, et al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 2001 14 : 270 295.
12. Kamal SM El Sayed Khalifa K. Immune modulation by helminthic infections: worms and viral infections. Parasite Immunol 2006 28 : 483 496.
13. Hayashi M. Clinical features of cerebral schistosomiasis, especially in cerebral and hepatosplenomegalic type. Parasitol Int 2003 52 : 375 383.
14. Prata A. Disease in schistosomiasis mansoni in Brazil. In : Mahmoud AA (ed.) : Schistosomiasis. London, Imperial College Press, 2001 : 297 332.
15. Friedman JF, Kanzaria HK McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 2005 21 : 386 392.
16. de Jesus AR, Silva A, Santana LB, et al. Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis 2002 185 : 98 105.
17. King CH. Disease in schistosomiasis haematobium. In : Mahmoud AA (ed.) : Schistosomiasis. London, Imperial College Press, 2001 : 265 295.
18. Hou XY, McManus DP, Gray DJ, et al. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China. Bull World Health Organ 2008 86 : 788 795.
19. Espirito Santo MC, Azeredo LM, Teles HM, Gryschek RC, Ferreira CS Amato Neto V. Abdominal ultrasound in the evaluation of fibrosis and portal hypertension in an area of schistosomiasis low endemicity. Rev Inst Med Trop Sao Paulo 2008 50 : 117 119.
20. Hatz C, Murakami H Jenkins JM. A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 3. Schistosoma japonicum. Acta Trop 1992 51 : 29 36.
21. Li YS, Kardorff R, Richter J, et al. Ultrasound organometry: the importance of body height adjusted normal ranges in assessing liver and spleen parameters among Chinese subjects with Schistosoma japonicum infection. Acta Trop 2004 92 : 133 138.
22. Richter J, Hatz C Haussinger D. Ultrasound in tropical and parasitic diseases. Lancet 2003 362 : 900 902.
23. Ouma J, El-Khoby T, Fenwick A Blanton R. Disease in schistosomiasis mansoni in Africa. In : Mahmoud AA (ed.) : Schistosomiasis. London, Imperial College Press, 2001 : 333 360.
24. Vennervald BJ Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis 2004 17 : 439 447.
25. Bezerra AS, D'Ippolito G, Caldana RP, et al. Differentiating cirrhosis and chronic hepatosplenic schistosomiasis using MRI. AJR Am J Roentgenol 2008 190 : W201 W207.
26. Ellis MK, Li Y, Hou X, Chen H McManus DP. sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica. Int J Parasitol 2008 38 : 717 723.
27. Martins-Leite P, Gazzinelli G, Alves-Oliveira LF, et al. Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni. Antimicrob Agents Chemother 2008 52 : 2780 2786.
28. Hsu SY, Hsu HF, Davis JR Lust GL. Comparative studies on the lesions caused by eggs of Schistosoma japonicum and Schistosoma mansoni in livers of albino mice and rhesus monkeys. Ann Trop Med Parasitol 1972 66 : 89 97.
29. Hurst MH, Lola SG Lindberg R. Immunomodulation of the hepatic egg granuloma in Schistosoma japonicum-infected pigs. Parasite Immunol 2006 28 : 681 686.
30. Hurst MH, Willingham AL, 3rd Lindberg R. Tissue responses in experimental schistosomiasis japonica in the pig: a histopathologic study of different stages of single low- or high-dose infections. Am J Trop Med Hyg 2000 62 : 45 56.
31. Hurst MH, Willingham AL Lindberg R. Experimental Schistosomiasis japonica in the pig: immunohistology of the hepatic egg granuloma. Parasite Immunol 2002 24 : 151 159.
32. Cheng YL, Song WJ, Liu WQ, et al. The effects of T cell deficiency on the development of worms and granuloma formation in mice infected with Schistosoma japonicum. Parasitol Res 2008 102 : 1129 1134.
33. Cheever AW, Eltoum IA, Andrade ZA Cox TM. Biology and pathology of Schistosoma mansoni and Schistosoma japonicum infections in several strains of nude mice. Am J Trop Med Hyg 1993 48 : 496 503.
34. Ji F, Liu Z, Cao J et al. B cell response is required for granuloma formation in the early infection of Schistosoma japonicum. PLoS ONE 2008 3 : e1724.
35. + T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med 1998 187 : 619 629.
36. Bartley PB, Ramm GA, Jones MK, Ruddell RG, Li Y McManus DP. A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int J Parasitol 2006.
37. Chang D, Ramalho LN, Ramalho FS, Martinelli AL Zucoloto S. Hepatic stellate cells in human schistosomiasis mansoni: a comparative immunohistochemical study with liver cirrhosis. Acta Trop 2006 97 : 318 323.
38. Zou W-L, Yang Z, Zang Y-J, Li D-J, Liang Z-P Shen Z-Y. Inhibitory effects of prostaglandin E1 on activation of hepatic stellate cells in rabbits with schistosomiasis. Hepatobiliary Pancreat Dis Int 2007 6 : 176 181.
39. Singh KP, Gerard HC, Hudson AP Boros DL. Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs. Ann Trop Med Parasitol 2004 98 : 581 593.
40. Singh KP, Gerard HC, Hudson AP Boros DL. Differential expression of collagen, MMP, TIMP and fibrogenic-cytokine genes in the granulomatous colon of Schistosoma mansoni-infected mice. Ann Trop Med Parasitol 2006 100 : 611 620.
41. Knittel T, Kobold D, Saile B, et al. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999 117 : 1205 1221.
42. Lenzi H, Romanha Wde S, Santos RZ, et al. Four whole-istic aspects of schistosome granuloma biology: fractal arrangement, internal regulation, autopoietic component and closure. Mem Inst Oswaldo Cruz 2006 101 : 219 231.
43. Hesse M, Modolell M, La Flamme AC, et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of 1-arginine metabolism. J Immunol 2001 167 : 6533 6544.
44. Stavitsky AB. Regulation of granulomatous inflammation in experimental models of schistosomiasis. Infect Immun 2004 72 : 1 12.
45. Pesce J, Kaviratne M, Ramalingam TR, et al. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 2006 116 : 2044 2055.
46. Song E, Ouyang N, Horbelt M, Antus B, Wang M Exton MS. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000 204 : 19 28.
47. Thompson RW, Pesce JT, Ramalingam T, et al. Cationic amino acid transporter-2 regulates immunity by modulating arginase activity. PLoS Pathog 2008 4 : e1000023.
48. Liu T, Dhanasekaran SM, Jin H, et al. FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol 2004 164 : 1315 1326.
49. Edungbola LD, Cha YN, Bueding E Schiller EL. Granuloma formation around exogenous eggs of Schistosoma mansoni and Schistosoma japonicum in mice. Afr J Med Med Sci 1982 11 : 75 79.
50. Monzawa S, Uchiyama G, Ohtomo K Araki T. Schistosomiasis japonica of the liver: contrast-enhanced CT findings in 113 patients. AJR Am J Roentgenol 1993 161 : 323 327.
51. Cerri GG, Alves VA Magalhaes A. Hepatosplenic schistosomiasis mansoni: ultrasound manifestations. Radiology 1984 153 : 777 780.
52. Manzella A, Ohtomo K, Monzawa S Lim JH. Schistosomiasis of the liver. Abdom Imaging 2008.
53. Oswald IP, Dozois CM, Barlagne R, Fournout S, Johansen MV Bogh HO. Cytokine mRNA expression in pigs infected with Schistosoma japonicum. Parasitology 2001 122 : 299 307.
54. Pearce EJ, Caspar P, Grzych JM, Lewis FA Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 1991 173 : 159 166.
55. Fallon PG, Richardson EJ, McKenzie GJ McKenzie AN. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 2000 164 : 2585 2591.
56. Cheever AW, Williams ME, Wynn TA, et al. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 1994 153 : 753 759.
57. Chensue SW, Warmington KS, Ruth J, Lincoln PM Kunkel SL. Cross-regulatory role of interferon-γ (IFN-γ), IL-4 and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation. Clin Exp Immunol 1994 98 : 395 400.
58. Hirata M, Kage M, Hara T, Yoneda Y, Zhang M Fukuma T. Schistosoma japonicum egg granuloma formation in the interleukin-4 or interferon-γ; deficient host. Parasite Immunol 2001 23 : 271 280.
59. Rumbley CA, Sugaya H, Zekavat SA, El Refaei M, Perrin PJ Phillips SM. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J Immunol 1999 162 : 1003 1009.
60. Yamashita T Boros DL. IL-4 influences IL-2 production and granulomatous inflammation in murine schistosomiasis mansoni. J Immunol 1992 149 : 3659 3664.
61. Kaviratne M, Hesse M, Leusink M, et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent. J Immunol 2004 173 : 4020 4029.
62. Sugimoto R, Enjoji M, Nakamuta M, et al. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int 2005 25 : 420 428.
63. Ramalingam TR, Pesce JT, Sheikh F, et al. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor [α]1 chain. Nat Immunol 2008 9 : 25 33.
64. Herbert DBR, Orekov T, Perkins C, Rothenberg ME Finkelman FD. IL-4Rα Expression by Bone Marrow-Derived Cells Is Necessary and Sufficient for Host Protection against Acute Schistosomiasis. J Immunol 2008 180 : 4948 4955.
65. Cheever AW, Xu YH, Sher A Macedonia JG. Analysis of egg granuloma formation in Schistosoma japonicum-infected mice treated with antibodies to interleukin-5 and γ interferon. Infect Immun 1991 59 : 4071 4074.
66. Reiman RM, Thompson RW, Feng CG, et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun 2006 74 : 1471 1479.
67. Cheever AW, Finkelman FD, Caspar P, Heiny S, Macedonia JG Sher A. Treatment with anti-IL-2 antibodies reduces hepatic pathology and eosinophilia in Schistosoma mansoni-infected mice while selectively inhibiting T cell IL-5 production. J Immunol 1992 148 : 3244 3248.
68. + cells after treatment with anti-interleukin-2 antibodies. Infect Immun 1993 61 : 1288 1292.
69. Swartz JM, Dyer KD, Cheever AW, et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 2006 108 : 2420 2427.
70. Lins RAB, Cavalcanti CBdL, Araújo-Filho JLS, Melo-Júnior MRd Chaves MEC. A distribuição dos eosinófilos nas diferentes fases de evolução do granuloma hepático em camundongos infectados pelo Schistosoma mansoni. Rev Soc Bras Med Trop 2008 41 : 173 178.
71. Hesse M, Piccirillo CA, Belkaid Y, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004 172 : 3157 3166.
72. Wynn TA, Cheever AW, Williams ME, et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 1998 160 : 4473 4480.
73. Todt JC, Whitfield JR, Ivard SR Boros DL. Down-regulation of interleukin-12, interleukin-12R expression/activity mediates the switch from Th1 to Th2 granuloma response during murine Schistosomiasis mansoni. Scand J Immunol 2000 52 : 385 392.
74. Hoffmann KF, Cheever AW Wynn TA. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 2000 164 : 6406 6416.
75. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 2007 13 : 139 145.
76. Rutitzky LI, Bazzone L, Shainheit MG, Joyce-Shaikh B, Cua DJ Stadecker MJ. IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17. J Immunol 2008 180 : 2486 2495.
77. Rutitzky LI, Lopes da Rosa JR Stadecker MJ. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 2005 175 : 3920 3926.
78. Rutitzky LI Stadecker MJ. CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis. Mem Inst Oswaldo Cruz 2006 101 (Suppl. 1 327 330.
79. Warren KS, Grove DI Pelley RP. The Schistosoma japonicum egg granuloma. II. Cellular composition, granuloma size, and immunologic concomitants. Am J Trop Med Hyg 1978 27 : 271 275.
80. Sher A, Coffman RL, Hieny S, Scott P Cheever AW. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 1990 87 : 61 65.
81. Yap G, Cheever A, Caspar P, Jankovic D Sher A. Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and γ interferon-deficient mice chronically infected with Schistosoma mansoni. Infect Immun 1997 65 : 2583 2586.
82. Bickle Q Helmby H. Lack of galectin-3 involvement in murine intestinal nematode and schistosome infection. Parasite Immunol 2007 29 : 93 100.
83. Breuilh L, Vanhoutte F, Fontaine J, et al. Galectin-3 modulates immune and inflammatory responses during helminthic infection: Impact of galectin-3 deficiency on the functions of dendritic cells. Infect Immun 2007 75 : 5148 5157.
84. Oliveira FL, Frazao P, Chammas R, et al. Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3/mice. J Leukoc Biol 2007 82 : 300 310.
85. Taylor JJ, Mohrs M Pearce EJ. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 2006 176 : 5839 5847.
86. + regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 2006 176 : 5374 5387.
87. + T cells during Schistosoma mansoni infection of mice. Parasite Immunol 2007 29 : 293 308.
88. Yang J, Zhao J, Yang Y, et al. Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma. Immunology 2007 120 : 8 18.
89. + Tregs and prevent development of colitis in mice. Exp Parasitol 2007 116 : 385 389.
90. Mentink-Kane MM, Cheever AW, Thompson RW, et al. IL-13 receptor α 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci USA 2004 101 : 586 590.
91. Chiaramonte MG, Mentink-Kane M, Jacobson BA, et al. Regulation and function of the interleukin 13 receptor α 2 during a T helper cell type 2-dominant immune response. J Exp Med 2003 197 : 687 701.
92. Mentink-Kane MM Wynn TA. Opposing roles for IL-13 and IL-13 receptor IL-13Ra2 in health and disease. Immunol Rev 2004 202 : 191 202.
93. + Th cells in granulomas: a novel effector mechanism involved in the control of egg-induced immunopathology in murine schistosomiasis. J Immunol 2003 171 : 1859 1867.
94. Souza ALS, Roffe E, Pinho V, et al. Potential role of the chemokine Macrophage Inflammatory Protein 1α in human and experimental schistosomiasis. Infect Immun 2005 73 : 2515 2523.
95. Jakubzick C, Wen H, Matsukawa A, Keller M, Kunkel SL Hogaboam CM. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am J Pathol 2004 165 : 1211 1221.
96. Souza PR, Souza AL, Negrao-Correa D, Teixeira AL Teixeira MM. The role of chemokines in controlling granulomatous inflammation in Schistosoma mansoni infection. Acta Trop 2008.
97. Falcao PL, Correa-Oliveira R, Fraga LA, et al. Plasma concentrations and role of macrophage inflammatory protein-1α during chronic Schistosoma mansoni infection in humans. J Infect Dis 2002 186 : 1696 1700.
98. Chensue SW, Warmington KS, Allenspach EJ, et al. Differential expression and cross-regulatory function of RANTES during mycobacterial (Type 1) and schistosomal (Type 2) antigen-elicited granulomatous inflammation. J Immunol 1999 163 : 165 173.
99. Chiu BC Chensue SW. Chemokine responses in schistosomal antigen-elicited granuloma formation. Parasite Immunol 2002 24 : 285 294.
100. Chiu B-C, Freeman CM, Stolberg VR, et al. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am J Respir Cell Mol Biol 2003 29 : 106 116.
101. Park MK, Hoffmann KF, Cheever AW, Amichay D, Wynn TA Farber JM. Patterns of chemokine expression in models of Schistosoma mansoni inflammation and infection reveal relationships between type 1 and type 2 responses and chemokines in vivo. Infect Immun 2001 69 : 6755 6768.
102. Qiu B, Frait KA, Reich F, Komuniecki E Chensue SW. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol 2001 158 : 1503 1515.
103. Souza AL, Sousa-Pereira SR, Teixeira MM, Lambertucci JR Teixeira AL. The role of chemokines in Schistosoma mansoni infection: insights from human disease and murine models. Mem Inst Oswaldo Cruz 2006 101 : 333 338.
104. Hoffmann KF, McCarty TC, Segal DH, et al. Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. FASEB J 2001 15 : 2545 2547.
105. Sandler NG, Mentink-Kane MM, Cheever AW Wynn TA. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol 2003 171 : 3655 3667.
106. Sakthianandeswaren A, Elso CM, Simpson K, et al. The wound repair response controls outcome to cutaneous leishmaniasis. Proc Natl Acad Sci USA 2005 102 : 15551 15556.
107. + T cell responses in mice infected with Schistosoma japonicum. Acta Biochimica et Biophysica Sinica 2006 38 : 327 334.
108. + T cells reveals an interferon signaling suppression associated with progression of experimental Schistosoma japonicum infection. Cell Immunol 2003 224 : 55 62.
109. Mwatha JK, Kimani G, Kamau T, et al. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol 1998 160 : 1992 1999.
110. Wilson S, Jones FM, Mwatha JK, et al. Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection. Infect Immun 2008 76 : 2212 2218.
111. de Morais CN, de Souza JR, Melo WG, et al. Cytokine profile associated with chronic and acute human schistosomiasis mansoni. Mem Inst Oswaldo Cruz 2008 103 : 561 568.
112. Teixeira-Carvalho A, Martins-Filho OA, Peruhype-Magalhaes V, et al. Cytokines, chemokine receptors, CD4 (+) CD25 (HIGH+) T-cells and clinical forms of human schistosomiasis. Acta Trop 2008.
113. Booth M, Mwatha JK, Joseph S, et al. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-γ, high TNF-α, or low RANTES, depending on age and gender. J Immunol 2004 172 : 1295 1303.
114. Coutinho HM, Acosta LP, Wu HW, et al. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis 2007 195 : 288 295.
115. Henri S, Chevillard C, Mergani A, et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-γ is associated with protection against fibrosis and TNF-α with aggravation of disease. J Immunol 2002 169 : 929 936.
116. Silveira-Lemos D, Teixeira-Carvalho A, Martins-Filho OA, et al. Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients. Acta Trop 2008.
117. Arnaud V, Li J, Wang Y, et al. Regulatory role of interleukin-10 and interferon-γ in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum. J Infect Dis 2008 198 : 418 426.
118. Coutinho HM, McGarvey ST, Acosta LP, et al. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 2005 192 : 528 536.
119. Blanton RE, Salam EA, Ehsan A, King CH Goddard KA. Schistosomal hepatic fibrosis and the interferon γ receptor: a linkage analysis using single-nucleotide polymorphic markers. Eur J Hum Genet 2005 13 : 660 668.
120. Campino S, Kwiatkowski D Dessein A. Mendelian and complex genetics of susceptibility and resistance to parasitic infections. Semin Immunol 2006 18 : 411 422.
121. Chevillard C, Moukoko CE, Elwali NE, et al. IFN-γ polymorphisms (IFN-γ +2109 and IFN-γ +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 2003 171 : 5596 5601.
122. Dessein AJ, Hillaire D, Elwali NE, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-γ receptor gene. Am J Hum Genet 1999 65 : 709 721.
123. Ellis MK, Li Y, Rong Z, Chen H McManus DP. Familial aggregation of human infection with Schistosoma japonicum in the Poyang Lake region, China. Int J Parasitol 2006 36 : 71 77.
124. Ellis MK, Zhao ZZ, Chen HG, Montgomery GW, Li YS McManus DP. Analysis of the 5q31 33 locus shows an association between single nucleotide polymorphism variants in the IL-5 gene and symptomatic infection with the human blood fluke, Schistosoma japonicum. J Immunol 2007 179 : 8366 8371.
125. Marquet S, Abel L, Hillaire D, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996 14 : 181 184.
126. Marquet S, Abel L, Hillaire D Dessein A. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur J Hum Genet 1999 7 : 88 97.
127. He H, Isnard A, Kouriba B, et al. A STAT6 gene polymorphism is associated with high infection levels in urinary schistosomiasis. Genes Immun 2008 9 : 195 206.
128. Chevillard C, Henri S, Stefani F, Parzy D Dessein A. Two new polymorphisms in the human interferon γ (IFN-γ) promoter. Eur J Immunogenet 2002 29 : 53 56.
129. Cabello PH, Krieger H, Lopes JD Sant'Ana EJ. On the association between HLA-A1 and B5 and clinical forms of schistosomiasis mansoni. Mem Inst Oswaldo Cruz 1991 86 : 37 40.
130. Secor WE, del Corral H, dos Reis MG, et al. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J Infect Dis 1996 174 : 1131 1135.
131. Waine GJ, Ross AG, Williams GM, Sleigh AC McManus DP. HLA class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum. Int J Parasitol 1998 28 : 537 542.
132. Hirayama K, Chen H, Kikuchi M, et al. HLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population. Tissue Antigens 1999 53 : 269 274.
133. McManus DP, Ross AG, Williams GM, et al. HLA class II antigens positively and negatively associated with hepatosplenic schistosomiasis in a Chinese population. Int J Parasitol 2001 31 : 674 680.
134. Hirayama K. Genetic factors associated with development of cerebral malaria and fibrotic schistosomiasis. Korean J Parasitol 2002 40 : 165 172.
135. King CH, Dickman K Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005 365 : 1561 1569.
136. Steinmann P, Keiser J, Bos R, Tanner M Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006 6 : 411 425.
137. Jia TW, Zhou XN, Wang XH, Utzinger J, Steinmann P Wu XH. Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull World Health Organ 2007 85 : 458 465.
138. Finkelstein JL, Schleinitz MD, Carabin H McGarvey ST. Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature. PLoS Negl Trop Dis 2008 2 : e158.
139. Bergquist R, Utzinger J McManus DP. Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis 2008 2 : e244.
140. McManus DP Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008 21 : 225 242.
141. Capron A, Riveau G, Capron M Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 2005 21 : 143 149.
142. James SL Colley DG. Progress in vaccine development. In : Mahmoud AA (ed.) : Schistosomiasis. London, Imperial College Press, 2001 : 469 495.
143. McManus DP Bartley PB. A vaccine against Asian schistosomiasis. Parasitol Int 2004 53 : 163 173.
144. Stadecker MJ, Asahi H, Finger E, Hernandez HJ, Rutitzky LI Sun J. The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol Rev 2004 201 : 168 179.
145. Liu F, Lu J, Hu W, et al. New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum. PLoS Pathog 2006 2 : e29.
146. Cass CL, Johnson JR, Califf LL, et al. Proteomic analysis of Schistosoma mansoni egg secretions. Mol Biochem Parasitol 2007 155 : 84 93.
147. Rutitzky LI, Hernandez HJ Stadecker MJ. Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc Natl Acad Sci USA 2001 98 : 13243 13248.
148. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007 117 : 524 529.
149. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008 214 : 199 210.